Solaraze and actinic keratosis: what to know

Actinic keratosis is a rough, scaly, or sandpaper-like patch caused by accumulated ultraviolet exposure. It may be easier to feel than see and can occur on the face, scalp, ears, forearms, or hands. Solaraze is a prescription gel containing diclofenac; it is applied to selected areas according to medical instructions. A rough patch is not automatically cancer, but some actinic keratoses can progress to squamous-cell carcinoma, so diagnosis and follow-up matter. Sun-damaged skin may contain more than one area needing review.

Use the gel only on the area and schedule prescribed, and wash your hands after application. Avoid eyes, lips, broken skin, and unnecessary sun exposure unless your clinician gives different instructions. Burning, redness, dryness, or irritation can occur; report severe or persistent reactions. Do not cover the area with a dressing or add another active treatment unless advised. Treatment choices may include cryotherapy, topical medicines, or photodynamic therapy depending on the number, location, thickness, and appearance of lesions.

Arrange a skin examination for a patch that bleeds, becomes tender, thickens, forms a sore, grows, or fails to settle as expected. Seek review if a treated area develops severe inflammation or signs of infection. Regular checks are useful because a new rough patch can appear even after another area has been treated; a clinician may recommend screening or follow-up based on your history.

Ask whether the spot needs a biopsy, why Solaraze is suitable, how to apply it, what reaction is expected, and whether another treatment or follow-up examination is more appropriate.